The measures are draconian and arbitrary, in particular the stock divestment requirements, and are without precedent in the federal government for employees outside of regulatory agencies, such as the FDA or Securities and Exchange Commission.The Assembly is combating a widely-held, but erroneous, impression that the NIH regulations are merely bringing the NIH into line with the ethics regulatio